Drug | Page 231 of 280 | SpiritIndia.com

Cervical Cancer :: Merck’s cervical cancer vaccine Gardasil in CDC’s Vaccines for Children

Merck & Co., Inc. announced that the U.S. Centers for Disease Control and Prevention (CDC) has added Merck’s cervical cancer vaccine, GARDASIL? [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the CDC’s Vaccines for Children (VFC) contract for girls and women aged 9 to 18. GARDASIL was approved on June 8 by the Food and Drug Administration (FDA) for use in girls and women ages 9 to 26 years. GARDASIL is the world’s first and only vaccine available for the prevention of HPV types 16- and 18-related cervical cancer, cervical pre-cancers (CIN 2/3 and AIS), vulvar pre-cancers (VIN 2/3) and vaginal pre-cancers (VaIN 2/3) and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by HPV types 6, 11, 16 and 18.

Chemotherapy :: Understanding Chemotherapy for breast cancer

Chemotherapy for breast cancer was first introduced 30 years ago, and doctors have been refining the treatment ever since. Countless studies have asked which drugs work best and when they should be given, but many women still have not realized the full benefits of chemotherapy.

Tuberculosis :: Pioneers in TB control from Africa and India receive awards for outstanding achievements

Two individuals who helped transform tuberculosis (TB) control in their home countries have become the first winners of a prestigious international health prize, to mark their contribution to improved TB control. The Stop TB Partnership Kochon Prize was inaugurated this year, and will be awarded for the first time, at the 37th Union World Conference on Lung Health, Palais des Congr?s, Paris.

Health :: Pharmion enrolled first patient into Vidaza Patient Registry

Pharmion Corporation (Nasdaq: PHRM) announced today the enrollment of the first patient in AVIDA(TM), a registry for patients treated with Vidaza(R) (azacitidine for injectable suspension). Vidaza was approved in May 2004 for the treatment of all five French-American-British (FAB) subtypes of myelodysplastic syndromes (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Myelodysplastic syndromes are a serious and life-threatening group of diseases in which the bone marrow does not function normally, resulting in the production of malformed or immature blood cells.

Exercise :: Regular exercise plays a role in reducing fatigue, increasing energy

Forget so-called ?energy drinks.? A new analysis by University of Georgia researchers finds overwhelming evidence that regular exercise plays a significant role in increasing energy levels and reducing fatigue.

Hepatitis :: Patients who recover from hepatitis C have lower risk of reinfection

A new study found that individuals who had tested positive for hepatitis C (HCV) but later tested negative for the virus were significantly less likely to become infected again compared to those who had never been infected, even though they had the same exposure risks.

Depression :: Regular follow-up important during antidepressant treatment

Because individuals can react differently to antidepressant medications, regular follow-up is important during the first few weeks of treatment, according to an editorial by Group Health psychiatrist and researcher Greg Simon, MD, MPH.

Depression :: Antidepressants linked to lower child suicide rates

Researchers report an inverse relationship between antidepressant prescriptions and the rates of suicide in children and adolescents — a finding that contradicts the Food and Drug Administration’s “black box” warning for selective serotonin reuptake inhibitor medications, also known as SSRI drugs.

Multiple Sclerosis :: More money for disease modifying drug therapies in Wales

On 30 October 2006, Dr Brian Gibbons, Health Minister for Wales, announced an additional ?700,000 funding for the beta interferons and glatiramer acetate. This should help to ensure that everyone with MS who lives in Wales and meets the prescribing criteria will be able to start treatment as soon as possible.

Kidney Stone :: Drug prescribed for migraines and seizures increases risk of kidney stones

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.